{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:42:32Z","timestamp":1794271352912,"version":"4.9.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The main aim of this study was to assess the expression level of circulating long non-coding RNA maternally expressed gene 3 (lncRNA-MEG3), microRNA (miR-125a-5P), the chemokine C-X-C motif ligand13 (CXCL13), and the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) in immune thrombocytopenia (ITP) cases and to study its relation to the disease severity and treatment response. This case-control study included 45 patients newly diagnosed as ITP and 45 healthy subjects. We assessed complete blood count, antinuclear antibodies, hepatitis B and C virus serology, lncRNA-MEG3, miR-125a-5P, and CXCL13 expression in serum by real-time PCR and NF-kb protein by ELISA. In ITP patients compared to control, lncRNA-MEG3 was significantly increased, and miRNA-125a-5P was decreased, and this was associated with higher CXCL13 and NF-kB levels (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u2009\n                    <jats:italic>0.001<\/jats:italic>\n                    , for all).There was a significant negative correlation between platelet count and lncRNA-MEG3, CXCL13, and NF-kb, while a positive correlation with miR-125a-5p in ITP patients. Patients who responded to steroids had significantly higher miR-125a-5p (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u2009\n                    <jats:italic>0.016<\/jats:italic>\n                    ) and significantly lower lncRNA-MEG3 (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u2009\n                    <jats:italic>0.001<\/jats:italic>\n                    ), CXCL13 (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u2009\n                    <jats:italic>0.005<\/jats:italic>\n                    ), and NF-kb (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u2009\n                    <jats:italic>0.002)<\/jats:italic>\n                    . Based on the ROC curves, lncRNA-MEG3 displayed the highest area under the curve (AUC) in the identification of organ bleeding (AUC\u2009=\u20090.805), the response to steroids (AUC\u2009=\u20090.853), and the need for splenectomy (AUC\u2009=\u20090.75).\n                  <\/jats:p>","DOI":"10.1038\/s41435-023-00200-3","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T03:03:15Z","timestamp":1681268595000},"page":"108-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Long non-coding RNA maternally expressed gene 3, miR-125a-5p, CXCL13, and NF-kB in patients with immune thrombocytopenia"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9345-1542","authenticated-orcid":false,"given":"Mervat","family":"Naguib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"El Sawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"AlHelf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Abdelgwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"200_CR1","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1182\/bloodadvances.2017009860","volume":"1","author":"CE Neunert","year":"2017","unstructured":"Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Blood Adv. 2017;1:2295\u2013301. https:\/\/doi.org\/10.1182\/bloodadvances.2017009860. Erratum in: Blood Adv. 2018;2:1817. PMID: 29296878; PMCID: PMC5737126.","journal-title":"Blood Adv"},{"key":"200_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1179\/1607845415Y.0000000032","volume":"21","author":"I Song","year":"2016","unstructured":"Song I, Kim J, Kwon K, Koo S, Jo D. Expression of CD154 (CD40L) on stimulated T lymphocytes in patients with idopathic thrombocytopenic purpura. Hematology. 2016;21:187\u201392. https:\/\/doi.org\/10.1179\/1607845415Y.0000000032.","journal-title":"Hematology"},{"key":"200_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/cells9030531","volume":"9","author":"I Raphael","year":"2020","unstructured":"Raphael I, Joern RR, Forsthuber TG. Memory CD4+ T Cells in Immunity and Autoimmune Diseases. Cells. 2020;9:531 https:\/\/doi.org\/10.3390\/cells9030531.","journal-title":"Cells"},{"key":"200_CR4","doi-asserted-by":"publisher","first-page":"104096","DOI":"10.1016\/j.cellimm.2020.104096","volume":"351","author":"M Kostic","year":"2020","unstructured":"Kostic M, Zivkovic N, Cvetanovic A, Marjanovi\u0107 G. CD4+ T cell phenotypes in the pathogenesis of immune thrombocytopenia. Cell Immunol 2020;351:104096 https:\/\/doi.org\/10.1016\/j.cellimm.2020.104096.","journal-title":"Cell Immunol"},{"key":"200_CR5","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.3390\/ijms21144886","volume":"21","author":"NY Ko","year":"2020","unstructured":"Ko NY, Chen LR, Chen KH. The Role of Micro RNA and Long-Non-Coding RNA in Osteoporosis. Int J Mol Sci 2020;21:4886 https:\/\/doi.org\/10.3390\/ijms21144886.","journal-title":"Int J Mol Sci"},{"key":"200_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2018.05.020","volume":"431","author":"S Hirschberger","year":"2018","unstructured":"Hirschberger S, Hinske LC, Kreth S. MiRNAs: dynamic regulators of immune cell functions in inflammation and cancer. Cancer Lett. 2018;431:11\u201321. https:\/\/doi.org\/10.1016\/j.canlet.2018.05.020.","journal-title":"Cancer Lett"},{"key":"200_CR7","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1136\/jim-2019-001020","volume":"67","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Zhu H, Xie X, Zheng Z, Ling Y. MicroRNA expression profile in Treg cells in the course of primary immune thrombocytopenia. J Investig Med 2019;67:1118\u201324. https:\/\/doi.org\/10.1136\/jim-2019-001020.","journal-title":"J Investig Med"},{"key":"200_CR8","doi-asserted-by":"publisher","first-page":"e26959","DOI":"10.1097\/MD.0000000000026959","volume":"100","author":"H Xue","year":"2021","unstructured":"Xue H, Gao H, Xia H, Li S, Li N, Duan Y, et al. Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia. Med (Balt). 2021;100:e26959 https:\/\/doi.org\/10.1097\/MD.0000000000026959.","journal-title":"Med (Balt)"},{"key":"200_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.biopha.2016.07.057","volume":"83","author":"JQ Li","year":"2016","unstructured":"Li JQ, Hu SY, Wang ZY, Lin J, Jian S, Dong YC, et al. Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of Treg\/Th17 in immune thrombocytopenic purpura. Biomed Pharmacother 2016;83:905\u201311. https:\/\/doi.org\/10.1016\/j.biopha.2016.07.057.","journal-title":"Biomed Pharmacother"},{"key":"200_CR10","doi-asserted-by":"publisher","first-page":"e86295","DOI":"10.1371\/journal.pone.0086295","volume":"9","author":"Y Shi","year":"2014","unstructured":"Shi Y, Wang Y, Luan W, Wang P, Tao T, Zhang J, et al. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS ONE. 2014;9:e86295 https:\/\/doi.org\/10.1371\/journal.pone.0086295.","journal-title":"PLoS ONE"},{"key":"200_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cellsig.2014.11.011","volume":"27","author":"P Wang","year":"2015","unstructured":"Wang P, Liu YH, Yao YL, Li Z, Li ZQ, Ma J, et al. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell Signal 2015;27:275\u201382. https:\/\/doi.org\/10.1016\/j.cellsig.2014.11.011.","journal-title":"Cell Signal"},{"key":"200_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3899\/jrheum.090450","volume":"37","author":"HT Lee","year":"2010","unstructured":"Lee HT, Shiao YM, Wu TH, Chen WS, Hsu YH, Tsai SF, et al. Serum BLC\/CXCL13 concentrations and renal expression of CXCL13\/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. J Rheumatol 2010;37:45\u201352. https:\/\/doi.org\/10.3899\/jrheum.090450.","journal-title":"J Rheumatol"},{"key":"200_CR13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/2326-6066.CIR-18-0517","volume":"7","author":"HH Workel","year":"2019","unstructured":"Workel HH, Lubbers JM, Arnold R, Prins TM, van der Vlies P, de Lange K, et al. A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer. Cancer Immunol Res. 2019;7:784\u201396. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0517.","journal-title":"Cancer Immunol Res"},{"key":"200_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3389\/fimmu.2018.00613","volume":"9","author":"B Miraghazadeh","year":"2018","unstructured":"Miraghazadeh B, Cook MC. Nuclear Factor-kappaB in Autoimmunity: Man and Mouse. Front Immunol 2018;9:613 https:\/\/doi.org\/10.3389\/fimmu.2018.00613.","journal-title":"Front Immunol"},{"key":"200_CR15","doi-asserted-by":"publisher","first-page":"8170436","DOI":"10.1155\/2018\/8170436","volume":"2018","author":"J Yu","year":"2018","unstructured":"Yu J, Hua M, Zhao X, Wang R, Zhong C, Zhang C, et al. NF-\u03baB-94ins\/del ATTG Genotype Contributes to the Susceptibility and Imbalanced Th17 Cells in Patients with Immune Thrombocytopenia. J Immunol Res 2018;2018:8170436 https:\/\/doi.org\/10.1155\/2018\/8170436.","journal-title":"J Immunol Res"},{"key":"200_CR16","first-page":"772","volume":"7","author":"JQ Li","year":"2015","unstructured":"Li JQ, Hu SY, Wang ZY, Lin J, Jian S, Dong YC, et al. MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia. Am J Transl Res 2015;7:772\u201380.","journal-title":"Am J Transl Res"},{"key":"200_CR17","doi-asserted-by":"publisher","first-page":"8676","DOI":"10.1080\/21655979.2022.2054501","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Bai J, Tuerdi N, Liu K. Long non-coding RNA MEG3 promotes tumor necrosis factor-alpha induced oxidative stress and apoptosis in interstitial cells of cajal via targeting the microRNA-21 \/I-kappa-B-kinase beta axis. Bioengineered 2022;13:8676\u201388. https:\/\/doi.org\/10.1080\/21655979.2022.2054501.","journal-title":"Bioengineered"},{"key":"200_CR18","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.1073\/pnas.1200081109","volume":"109","author":"SW Kim","year":"2012","unstructured":"Kim SW, Ramasamy K, Bouamar H, Lin AP, Jiang D, Aguiar RC. MicroRNAs miR-125a and miR-125b constitutively activate the NF-\u03baB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc Natl Acad Sci USA 2012;109:7865\u201370. https:\/\/doi.org\/10.1073\/pnas.1200081109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"200_CR19","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1182\/blood-2012-07-442392","volume":"121","author":"F Rodeghiero","year":"2013","unstructured":"Rodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel JB, et al. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood 2013;121:2596\u2013606. https:\/\/doi.org\/10.1182\/blood-2012-07-442392.","journal-title":"Blood"},{"key":"200_CR20","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019;3:3780\u2013817. https:\/\/doi.org\/10.1182\/bloodadvances.2019000812.","journal-title":"Blood Adv"},{"key":"200_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.meegid.2017.03.030","volume":"51","author":"O Shaker","year":"2017","unstructured":"Shaker O, Alhelf M, Morcos G, Elsharkawy A. miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma. Infect Genet Evol 2017;51:173\u201381. https:\/\/doi.org\/10.1016\/j.meegid.2017.03.030.","journal-title":"Infect Genet Evol"},{"key":"200_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.29252\/rbmb.9.2.230","volume":"9","author":"O Shaker","year":"2020","unstructured":"Shaker O, Mahfouz H, Salama A, Medhat E. Long Non-Coding HULC and miRNA-372 as Diagnostic Biomarkers in Hepatocellular Carcinoma. Rep. Biochem Mol Biol 2020;9:230\u201340. https:\/\/doi.org\/10.29252\/rbmb.9.2.230.","journal-title":"Rep. Biochem Mol Biol"},{"key":"200_CR23","first-page":"71","volume":"3","author":"X Rao","year":"2013","unstructured":"Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2\u02c6(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath 2013;3:71\u201385.","journal-title":"Biostat Bioinforma Biomath"},{"key":"200_CR24","unstructured":"Fang L, Liu J, Wan L, Zhu F, Tan B, Zhang P. [Xinfeng capsule improves hypercoagulative state by inhibiting miR-155\/NF-\u03baB signaling pathway in patients with active ankylosing spondylitis]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016;32:1094\u20138. Chinese."},{"key":"200_CR25","doi-asserted-by":"publisher","first-page":"850998","DOI":"10.3389\/fimmu.2022.850998","volume":"13","author":"Z Pan","year":"2022","unstructured":"Pan Z, Zhu T, Liu Y, Zhang N. Role of the CXCL13\/CXCR5 Axis in Autoimmune Diseases. Front Immunol. 2022;13:850998 https:\/\/doi.org\/10.3389\/fimmu.2022.850998.","journal-title":"Front Immunol"},{"key":"200_CR26","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1182\/blood-2011-01-332106","volume":"118","author":"J S\u00e1ez de Guinoa","year":"2011","unstructured":"S\u00e1ez de Guinoa J, Barrio L, Mellado M, Carrasco YR. CXCL13\/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics. Blood 2011;118:1560\u20139. https:\/\/doi.org\/10.1182\/blood-2011-01-332106.","journal-title":"Blood"},{"key":"200_CR27","doi-asserted-by":"publisher","first-page":"716469","DOI":"10.3389\/fimmu.2021.716469","volume":"12","author":"L Barnabei","year":"2021","unstructured":"Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F, Weil R. NF-\u03baB: At the Borders of Autoimmunity and Inflammation. Front Immunol. 2021;12:716469 https:\/\/doi.org\/10.3389\/fimmu.2021.716469.","journal-title":"Front Immunol"},{"key":"200_CR28","doi-asserted-by":"publisher","first-page":"9128","DOI":"10.1111\/jcmm.16743","volume":"25","author":"CC Chao","year":"2021","unstructured":"Chao CC, Lee WF, Wang SW, Chen PC, Yamamoto A, Chang TM, et al. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer. J Cell Mol Med 2021;25:9128\u201340. https:\/\/doi.org\/10.1111\/jcmm.16743.","journal-title":"J Cell Mol Med"},{"key":"200_CR29","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.3390\/ijms21176095","volume":"21","author":"JF Liu","year":"2020","unstructured":"Liu JF, Lee CW, Lin CY, Chao CC, Chang TM, Han CK, et al. CXCL13\/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma. Int J Mol Sci 2020;21:6095 https:\/\/doi.org\/10.3390\/ijms21176095.","journal-title":"Int J Mol Sci"},{"key":"200_CR30","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3389\/fimmu.2018.01377","volume":"9","author":"A Tahamtan","year":"2018","unstructured":"Tahamtan A, Teymoori-Rad M, Nakstad B, Salimi V. Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment. Front Immunol 2018;9:1377 https:\/\/doi.org\/10.3389\/fimmu.2018.01377.","journal-title":"Front Immunol"},{"key":"200_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1348-2","volume":"18","author":"FP Marchese","year":"2017","unstructured":"Marchese FP, Raimondi I, Huarte M. The multidimensional mechanisms of long noncoding RNA function. Genome Biol 2017;18:206 https:\/\/doi.org\/10.1186\/s13059-017-1348-2.","journal-title":"Genome Biol"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41435-023-00200-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-023-00200-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-023-00200-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T12:05:25Z","timestamp":1681733125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-023-00200-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["200"],"URL":"https:\/\/doi.org\/10.1038\/s41435-023-00200-3","relation":{},"ISSN":["1476-5470"],"issn-type":[{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}